James H. Cavanaugh's most recent trade in Leap Therapeutics Inc was a trade of 213 Common Stock done at an average price of $2.8 . Disclosure was reported to the exchange on Nov. 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | James H. Cavanaugh | Director | 13 Nov 2024 | 213 | 213 (0%) | 0% | 2.8 | 601 | Common Stock | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | 13 Nov 2024 | 213 | 0 | - | - | Warrant (Right to Buy) | ||
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Other type of transaction at price $ 0.00 per share. | 09 Feb 2021 | 1,154 | 1,154 | - | - | Warrant (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 32,300 | 32,300 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |